TYSON KAY: Open Payments
NPI 1538694468 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,089 in 43 payments from 12 companies in 2025. Trend: 2023 $433 · 2024 $927 · 2025 $1,089
Food & beverage: $1,089
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $330 |
| HARMONY BIOSCIENCES LLC | 4 | $140 |
| ABBVIE INC. | 7 | $123 |
| Alpha Cognition USA, Inc. | 1 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $87 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Viatris Specialty LLC | 3 | $81 |
| Verona Pharma, Inc. | 2 | $50 |
| Lilly USA, LLC | 2 | $39 |
| Eisai Inc. | 1 | $18 |
Products named: AIRSUPRA, WAKIX, VRAYLAR, Zunveyl, Kerendia, TRELEGY ELLIPTA, YUPELRI, FARXIGA.
Industry payments across NM — which companies pay providers there.
